Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles

Experimental and Molecular Pathology

Volumn 87, Issue 1, 2009, Pages 63-69

  Hussein, Mahmoud R ^a,b  

^a Assiut University   (Egypt)

^b ASEER CENTRAL HOSPITAL   (Saudi Arabia)

Author keywords

BCL2; Mole; p53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; LIGAND; MONOCLONAL ANTIBODY; PEROXIDASE; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL SURVIVAL; CHORION VILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIRST TRIMESTER PREGNANCY; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; LIGAND BINDING; MORPHOGENESIS; PATHOGENESIS; PLACENTA; PROTEIN EXPRESSION; PROTO ONCOGENE; STAINING; TROPHOBLAST; TROPHOBLASTIC TUMOR; TUMOR SUPPRESSOR GENE;

FEMALE; HUMANS; HYDATIDIFORM MOLE; MORPHOGENESIS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS;

EID: 67649422171     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.03.005     Document Type: Article

References (32)

1. Adly M.A., Assaf H.A., and Hussein M.R. Expression pattern of p75 neurotrophin receptor protein in human scalp skin and hair follicles: hair cycle-dependent expression. J. Am. Acad. Dermatol. 60 (2009) 99-109
2. Al-Bozom I.A. p53 and Bcl-2 oncoprotein expression in placentas with hydropic changes and partial and complete moles. Apmis 108 (2000) 756-760
3. Bulmer J.N., Thrower S., and Wells M. Expression of epidermal growth factor receptor and transferrin receptor by human trophoblast populations. Am. J. Reprod. Immunol. 21 (1989) 87-93
4. Chen C.A., Chen Y.H., Chen T.M., Ko T.M., Wu C.C., Lee C.N., and Hsieh C.Y. Infrequent mutation in tumor suppressor gene p53 in gestational trophoblastic neoplasia. Carcinogenesis 15 (1994) 2221-2223
5. Cheung A.N., Srivastava G., Chung L.P., Ngan H.Y., Man T.K., Liu Y.T., Chen W.Z., Collins R.J., Wong L.C., and Ma H.K. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas. J. Reprod. Med. 39 (1994) 223-227
6. Cheville J.C., Robinson R.A., and Benda J.A. p53 expression in placentas with hydropic change and hydatidiform moles. Mod. Pathol. 9 (1996) 392-396
7. Fulop V., Mok S.C., Genest D.R., Gati I., Doszpod J., and Berkowitz R.S. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J. Reprod. Med. 43 (1998) 119-127
8. Giudice L.C. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil. Steril. 61 (1994) 1-17
9. Hussein M.R. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt. Liver Int. 24 (2004) 552-560
10. Hussein M.R. The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?. Tumour. Biol. 25 (2004) 200-207
11. Hussein M.R. Alterations of p53 and Bcl-2 protein expression in the laryngeal intraepithelial neoplasia. Cancer Biol. Ther. 4 (2005) 213-217
12. Hussein M.R. Apoptosis in the ovary: molecular mechanisms. Hum. Reprod. Update 11 (2005) 162-177
13. Hussein M.R., and Ismael H.H. Alterations of p53, Bcl-2, and hMSH2 protein expression in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas in the upper Egypt. Cancer Biol. Ther. 3 (2004) 983-988
14. Hussein M.R., Haemel A.K., and Wood G.S. p53-related pathways and the molecular pathogenesis of melanoma. Eur. J. Cancer Prev. 12 (2003) 93-100
15. Hussein M.R., Bedaiwy M.A., and Falcone T. Analysis of apoptotic cell death, Bcl-2, and p53 protein expression in freshly fixed and cryopreserved ovarian tissue after exposure to warm ischemia. Fertil. Steril. 85 Suppl. 1 (2006) 1082-1092
16. Hussein M.R., Aref E.E., Yassen D.G., and Ramadan M.O. Analysis of hMSH2 mismatch repair protein expression in dysplasia, carcinoma in situ and invasive squamous cell carcinoma of the vocal folds. Cancer Invest. 27 (2009) 38-46
17. Hu W., Feng Z., Atwal G.S., and Levine A.J. p53: a new player in reproduction. Cell Cycle 7 (2008) 848-852
18. Ladines-Llave C.A., Maruo T., Manalo A.M., and Mochizuki M. Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts. Cancer 71 (1993) 4118-4123
19. Persaud V., Ganjei P., and Nadji M. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease. West Indian Med. J. 42 (1993) 142-143
20. Petignat P., Laurini R., Goffin F., Bruchim I., and Bischof P. Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta. Int. J. Gynecol. Cancer 16 (2006) 1679-1684
21. Qiao S., Nagasaka T., Harada T., and Nakashima N. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. Placenta 19 (1998) 361-369
22. Sakuragi N., Matsuo H., Coukos G., Furth E.E., Bronner M.P., VanArsdale C.M., Krajewsky S., Reed J.C., and Strauss III J.F. Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage. J. Soc. Gynecol. Investig. 1 (1994) 164-172
23. Shaarawy M., and Sheiba M. Diagnostic and prognostic significance of circulating tumor suppressor gene p53 autoantibodies in patients with gestational trophoblastic tumors. Acta Oncol. 43 (2004) 43-48
24. Shi Y.F., Xie X., Zhao C.L., Ye D.F., Lu S.M., Hor J.J., and Pao C.C. Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours. Br. J. Cancer 73 (1996) 1216-1219
25. Tuncer Z.S., Vegh G.L., Fulop V., Genest D.R., Mok S.C., and Berkowitz R.S. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol. Oncol. 77 (2000) 389-393
26. Ushizawa K., Takahashi T., Kaneyama K., Hosoe M., and Hashizume K. Cloning of the bovine antiapoptotic regulator, BCL2-related protein A1, and its expression in trophoblastic binucleate cells of bovine placenta. Biol. Reprod. 74 (2006) 344-351
27. Wang D.P., Fujii S., Konishi I., Nanbu Y., Iwai T., Nonogaki H., and Mori T. Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta. Virchows Arch. A. Pathol. Anat. Histopathol. 420 (1992) 385-393
28. Wei P., Jin X., Zhang X.S., Hu Z.Y., Han C.S., and Liu Y.X. Expression of Bcl-2 and p53 at the fetal-maternal interface of rhesus monkey. Reprod. Biol. Endocrinol. 3 (2005) 4
29. Wong S.Y., Ngan H.Y., Chan C.C., and Cheung A.N. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod. Pathol. 12 (1999) 1025-1033
30. Xiang Y., Li Z., Cui Q., Yang X., and Song H. [Expression of epidermal growth factor receptor in gestational trophoblastic tumours]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 22 (2000) 555-557
31. Yamauchi H., Katayama K., Ueno M., He X.J., Mikami T., Uetsuka K., Doi K., and Nakayama H. Essential role of p53 in trophoblastic apoptosis induced in the developing rodent placenta by treatment with a DNA-damaging agent. Apoptosis 12 (2007) 1743-1754
32. Yang X., Zhang Z., Jia C., Li J., Yin L., and Jiang S. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole. Gynecol. Oncol. 85 (2002) 438-444